ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

ACS Increases Funding for Scholar Grants; NCI Posts Interim FY2001 Funding Policy.

December 1, 2000

Francis Collins Nominated For NIH Director Two Days After Final Stem Cell Guidelines Released.

July 10, 2009

Adjuvant BC Therapy Is Topic Of NIH Consensus Conference.

January 28, 2000

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

Specialists List 15 Criteria For Choosing Health Insurance.

January 14, 2000

AACR 2001 Honorary Awards Announced; Nora Janjan Is ASTRO President-Elect.

January 5, 2001